Accessibility settings

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (1327) Methods and Feasibility Studies (733) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (2333) mHealth for Treatment Adherence (617) Pharmacology and Pharmaceutics (159) E-Health / Health Services Research and New Models of Care (1163) Pulmonology, COPD (230)

Published on in Vol 15 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/82806, first published .
Man holding asthma inhaler, managing respiratory health.

Evaluation of a Tailored Multifaceted Pharmaceutical Care Intervention to Optimize Chronic Obstructive Pulmonary Disease Management: Protocol for a Cluster Randomized Controlled Trial

Evaluation of a Tailored Multifaceted Pharmaceutical Care Intervention to Optimize Chronic Obstructive Pulmonary Disease Management: Protocol for a Cluster Randomized Controlled Trial

Authors of this article:

Xuedi Ma1 Author Orcid Image ;   Xiaocong Li2 Author Orcid Image ;   Xinyi Li2 Author Orcid Image ;   Hui Chen2 Author Orcid Image ;   Yang Wang1 Author Orcid Image ;   Xuan Jia1 Author Orcid Image ;   Yanyan Zhao1 Author Orcid Image ;   Wei Li1 Author Orcid Image ;   Lihong Liu2 Author Orcid Image
Article Authors Cited by (1) Tweetations Metrics

Journals

  1. Ma X, Li X, Shi C, Wang Y, Li W, Liu L. Medication burden, adherence and health-related quality of life in COPD in China: a multilevel health system study. BMJ Public Health 2026;4(2):e004558 View